| |
|
|
|
|
|
|
|||
|
D Hebbert and EH Morgan
Seven antagonists of the calcium-binding protein calmodulin were found to
inhibit iron and transferrin uptake by reticulocytes. This inhibition could
be completely accounted for by inhibition of the endocytosis and exocytosis
of transferrin. When four of the antagonists were tested with the nucleated
erythroid cells from the liver of the fetal rat, inhibition of iron uptake
was also observed but at higher concentrations than required for the same
degree of inhibition with reticulocytes. The tumor promoters phorbol
12-myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDB) were shown
to increase the rates of iron and transferrin uptake by reticulocytes and
fetal liver erythroid cells by accelerating the rates of transferrin
endocytosis and exocytosis. Since these substances are known to stimulate
the calcium-activated enzyme protein kinase C while calmodulin antagonists
are inhibitory, it is concluded that this enzyme plays an important role in
the endocytosis and intracellular cycling of transferrin, and iron uptake
by immature erythroid cells. However, the possibilities that calmodulin is
also involved or that the inhibitory effects of the calmodulin antagonists
are due to nonspecific actions on the cell membrane cannot be excluded.
This article has been cited by other articles:
| ||||||||||
| Copyright © 1985 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||